TABLE 2.

Primers used in this study.

Primers	Sequence (5’–3’)	Source or reference
For mutant construction
wecA-up-F/R	CTGTCGACAACAATGACCATACCGAGTAATAAGC TTTGTGGTGTCGTTCGCCAGTCTGAGTCGTATGAA ACGCAGAGCGAAAAG	This study
wecA-down-F/R	CTTTTCGCTCTGCGTTTCATACGACTCAGACTGGC GAACGACACCACAAA ATGCGGCCGCCCTAATGCGACACGGAAACC	This study
wecA-extrrior-F/R	ACCGATTTCCGGCGCAAGAG TGGCGAAGCAAAGAACAGTAATAGAG	This study
wecA-interior-F/R	TGCCCTTGACCTTGGGTGCTA TCTTGCGGCGGTGACTATTCTA	This study
For complement construction
wecA-F/R	GCGTCGACATGTGGCTTACTTTTCTTGCTGTTT TAGCGGCCGCTTACTCACTACCGATTTTGAGCTTTCTTTTC	This study
For qRT-PCR
16S rRNA-F/R	CCATGCCGCGTGAATGA TTCCTCGCTACCGAAAGAACTT	Subashchandrabose et al., 2013
WecA-F/R	ATACGCCGATGGTAGAGCAA ATCGATATGGTGGCGGTCAT	This study
For emsa assay
WecA-E-F/R	CTGAATAGCGTTGATCGACAAGGTT	This study
	GGGGTTAGCTCCCTCAAAATCAATA